Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRAIN - A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.

NCT07268339 is registered in ClinicalTrials.gov with The Christie NHS Foundation Trust as lead sponsor.

NCT NCT07268339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07268339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRAIN - A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.
Lead sponsor
The Christie NHS Foundation Trust
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 1, 2025
Completion date
December 1, 2031
Enrollment
328 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk non-muscle invasive bladder cancer